Valuation : Safe Fertility Group

Market Cap 1.6B 48.52M 41.75M 39.28M 35.89M 67.13M 4.58B 67.32M 464M 180M 2.35B 182M 178M 7.57B P/E 2026 *
12.5x
P/E 2027 * 11.3x
Enterprise Value 1.6B 48.52M 41.75M 39.28M 35.89M 67.13M 4.58B 67.32M 464M 180M 2.35B 182M 178M 7.57B EV / Sales 2026 *
2.29x
EV / Sales 2027 * 2.07x
Free-Float
23.1%
Yield 2026 *
7.05%
Yield 2027 * 7.62%
08-07 Safe Fertility Group Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
05-07 Safe Fertility Group Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
02-20 Safe Fertility Group Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2025 CI
02-18 Safe Fertility Group Public Company Limited announces Annual dividend, payable on May 22, 2026 CI
11-06 Safe Fertility Group Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
25-08-06 Safe Fertility Group Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
25-05-07 Safe Fertility Group Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25-04-29 Safe Fertility Group Public Company Limited Approves Dividend for the Year 2024, Payable on 23 May 2025 CI
25-02-19 Safe Fertility Group Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2024 CI
25-02-19 Safe Fertility Group Public Company Limited announces Annual dividend, payable on May 23, 2025 CI
24-11-06 Safe Fertility Group Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
24-11-01 125,378,468 Ordinary Shares of Safe Fertility Group Public Company Limited are subject to a Lock-Up Agreement Ending on 2-NOV-2024. CI
24-08-06 Safe Fertility Group Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
1 week-1.87%
Current month-0.94%
1 month-2.78%
3 months-9.48%
6 months-13.93%
Current year-17.32%
1 week 5.15
Extreme 5.15
5.4
1 month 5.15
Extreme 5.15
5.45
Current year 5.15
Extreme 5.15
6.9
1 year 5.15
Extreme 5.15
7.95
3 years 5.15
Extreme 5.15
23.7
5 years 5.15
Extreme 5.15
23.7
10 years 5.15
Extreme 5.15
23.7
Manager TitleAgeSince
Chief Executive Officer 60 2006-12-31
Director of Finance/CFO 45 -
Chief Operating Officer 59 2009-07-19
Director TitleAgeSince
Director/Board Member 60 2006-12-31
Director/Board Member 59 2009-07-19
Director/Board Member 59 -
Date Insider Type Main position Quantity % Market Cap. Importance
1/20/26 Buy

Chief Executive Officer

10,000 0.0033%
1/19/26 Buy

Chief Executive Officer

62,000 0.0204%
1/12/26 Buy

Chief Executive Officer

27,500 0.0090%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-1.87%-25.00% - 48.52M
-0.47%+3.95%+31.12%+47.45% 124B
-1.03%-3.07%-3.75%+47.68% 87.68B
-1.35%-4.85%-6.81%+51.86% 28.56B
-0.94%-2.32%+29.24%+86.37% 26.17B
+0.96%-3.57%-5.10%-7.78% 21.46B
+0.59%-0.66%+35.11%+245.84% 21.34B
-0.70%+4.77%-5.52%+29.24% 15.8B
+1.61%-1.75%-6.60%-7.93% 12.08B
+1.28%+1.83%+33.45%+90.37% 11.73B
Average -0.01%-0.65%+7.61%+64.79% 34.86B
Weighted average by Cap. -0.44%+0.05%+14.22%+58.24%

Financials

2026 *2027 *
Net sales 698M 21.22M 18.26M 17.18M 15.7M 29.37M 2B 29.45M 203M 78.8M 1.03B 79.7M 77.96M 3.31B 772M 23.48M 20.2M 19.01M 17.36M 32.48M 2.22B 32.57M 225M 87.15M 1.14B 88.15M 86.23M 3.66B
Net income 128M 3.89M 3.35M 3.15M 2.88M 5.39M 367M 5.4M 37.24M 14.45M 189M 14.62M 14.3M 607M 142M 4.3M 3.7M 3.48M 3.18M 5.95M 406M 5.97M 41.16M 15.97M 208M 16.16M 15.8M 671M
Net Debt - -
Logo Safe Fertility Group
Safe Fertility Group Public Company Limited is a Thailand-based company engaged in providing an obstetrics and gynecology hospital. It is also engaged in the business of medical laboratory and cosmetic dermatology. The Company's segments are Obstetrics and Gynecology Hospital and Medical Laboratory, and Cosmetic Dermatology. Its services include In Vitro Fertilization/Intracytoplasmic Sperm Injection (IVF/ICSI), Intrauterine Insemination (IUI), Egg Freezing, Embryo Transfer, Sperm Freezing, Sperm Analysis, Magnetic Activated Cell Sorting (MACS) Sperm, Intracytoplasmic Morphologically Selected Sperm Injection (IMSI), Testicular Sperm Extraction/Percutaneous Epididymal Sperm Aspiration (TESE/PESA), Couple Check-Up, EmbryoScope Plus, Preimplantation Genetic Testing for Aneuploidy (PGT-A), Preimplantation Genetic Testing for Monogenic Disorders (PGT-M), and Acupuncture. The Company's subsidiaries include Next Generation Genomics Co., Ltd., and Safe Wellness Company Limited.
Employees
-
Date Price Change Volume
26-09-04 THB 5.250 0.00% 26,300
26-09-03 THB 5.250 +0.96% 17,200
26-09-02 THB 5.200 0.00% 91,200
26-09-01 THB 5.200 -1.89% 218,160
26-08-31 THB 5.300 -0.93% 180,455
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
5.250THB
Average target price
8.525THB
Spread / Average Target
+62.38%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SAFE Stock